After premetastatic niche formation, MDSCs interact with tumor cells through the IL-6 receptor (IL-6R) and epidermal growth factor receptor (EGFR), thereby inducing the progression of bone metastasis of cancer cells [100]. The gene discussed is EGFR; the disease is cancer.